Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Manchester University Foundation Trust | Charity Commission: 1049274 | £1,650,000 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £1,650,000 initial term | 1 single bid — no competition | Manchester University Foundation Trust | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using Direct Award Process C.
The contract value is £1,650,000 commencing 01 April 2026 to 31 March 2029.
The award decision was made on 16 March 2026 by NHS England North West Specialised Commisisoning Senior Leaders Team:
Andrew Bibby, Regional Director of Specialised Commissioning and Health & Justice North West
Janine Dyson, Head of Quality
Carole Hodgkinsom, Head of Commercial Management
Sue McGorry, Director of Nursing
Fiona Simmons-Jones, Consultant in Healthcare, Public Health
Luoise Sinnott, Head of Acute Strategy and Transformation
Carol Stubley, Director of Finance
The existing provider is satisfying the existing contract and will likely satisfy the proposed new contract. The provider has been assessed and has passed against the relevant 5 key criteria and mandatory requirements award criteria which were laid out in the procurement documents.
There were no conflicts of interests identified.